Table 1.
PCP-Reported Characteristics
| Characteristics | No. (weighted %) |
|---|---|
| Individual | |
| Specialty | |
| General medicine | 72 (45.0) |
| Family medicine | 79 (50.0) |
| Other | 8 (5.1) |
| Years in practice | |
| 1–9 years | 25 (15.8) |
| 10–19 years | 34 (21.0) |
| 20–29 years | 55 (35.3) |
| 30 + years | 44 (27.9) |
| Gender | |
| Female | 74 (47.1) |
| Male | 84 (52.9) |
| Race | |
| White | 103 (67.3) |
| Non-White | 52 (32.7) |
| Clinical guidelines read | |
| ATA or NCCN or both | 44 (27.9) |
| None | 111 (72.1) |
| Most influential source in treating thyroid cancer | |
| Training in medical school/residency | 36 (22.5) |
| Clinical guidelines | 88 (54.3) |
| Colleagues in practice | 64 (39.1) |
| Employer established treatment guidelines | 7 (4.2) |
| National meetings | 28 (17.6) |
| Experts in my field | 33 (20.2) |
| Journal articles | 39 (24.4) |
| Practice | |
| Main practice location | |
| Large medical center | 37 (25.9) |
| Private | 103 (74.1) |
| Number of patients seen/typical week | |
| ≤75 | 52 (32.9) |
| 76-100 | 63 (39.6) |
| >100 | 44 (27.5) |
| Attitudes and beliefs | |
| PCP have the skills necessary to initiate appropriate screening to detect recurrent thyroid cancer | 98 (62.0) |
| PCPs should have responsibility for providing continuing care after treatment | 84 (53.0) |
*ATA = 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer
*NCCN = National Comprehensive Cancer Network’s 2017 “Thyroid Carcinoma: Clinical Practice Guidelines in Oncology”